01 11Erbitux
02 1Erbitux
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 536
2019 Revenue in Millions : 543
Growth (%) : -1
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 548
2020 Revenue in Millions : 536
Growth (%) : 2
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 567
2021 Revenue in Millions : 548
Growth (%) : 3
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 597
2022 Revenue in Millions : 567
Growth (%) : 5
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 3.90%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 723
2014 Revenue in Millions : 501
Growth (%) : -31%
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 373
2014 Revenue in Millions : 485
Growth (%) : 30%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : Not Reported
2015 Revenue in Millions : 501
Growth (%) : -100
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 687
2015 Revenue in Millions : 485
Growth (%) : 42
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 646
2016 Revenue in Millions : 687
Growth (%) : -6
LOOKING FOR A SUPPLIER?
